Abstract
A novel flow injection procedure to determine N-acetylcysteine and captopril in pharmaceutical formulations is proposed. The flow procedure developed was based on oxidation of the analytes by Fe(III) in acidic medium and subsequent reaction of the Fe(II) generated with excess hexacyanoferrate(III) to produce soluble Prussian blue (KFe[Fe(CN)6]) measured at 700 nm. Detection limits of 1.0 × 10−5 mol L−1 and 3.0 × 10−5 mol L−1 for N-acetylcysteine and captopril, respectively, were found. The sample throughput was 70 h−1 for both analytes and the results obtained were in agreement at a 95% confidence level with those obtained using reference methods.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
